CENTOGENE AG announced that it has signed a Memorandum of Understanding (MOU) with the Ministry of Health & Social Protection of the Population, Republic of Tajikistan. The MOU collaboration framework is intended to stimulate and facilitate the wellbeing of patients with genetic diseases, advance international scientific research, and enhance medical education in Tajikistan on issues related to the diagnostics of rare diseases.
CENTOGENE today revealed the growth in its knowledge-base of rare hereditary diseases. In today’s update to CentoMD® ̶ the Company’s […]
CENTOGENE today announced the initiation of ‘PICOPglobal’ ̶ a 24-month global proof-of concept study focusing on the identification of tumor-specific […]
In a paper published in June 2019 in the International Journal of Molecular Sciences, a four-year study of 81 children […]
In einem heute veröffentlichten Whitepaper stellt CENTOGENE den Fortschritt seines internen Programms zum Einsatz Künstlicher Intelligenz (KI) (engl.: Artificial Intelligence) […]
In a whitepaper published today, CENTOGENE revealed the progress it is making with its in-house artificial intelligence (AI) program to […]
Research findings may provide deeper understanding on the role of genes that can contribute to development of Hypophosphatasia.
One of the largest, most ethnically diverse studies of Parkinson’s disease to uncover the genetic basis of one of the most common neurodegenerative disorders
In a whitepaper released today, CENTOGENE provided an update on its induced pluripotent stem cells (iPSC) program. Launched in early 2019, the program is focused on supporting pharmaceutical companies for faster and cheaper orphan drug development for neurodegenerative, metabolic, and cardiovascular diseases.
CENTOGENE today welcomed Germany’s Chancellor Dr. Angela Merkel to its headquarters together with Manuela Schwesig, Minister-President of Mecklenburg-Vorpommern. The visit […]
Die verschiedenen nationalen Gremien und Kuratorien diskutieren intensiv die nötigen Voraussetzungen und den Nutzen der Digitalisierung, auch in unserem Bundesland […]
CENTOGENE today announced the expansion of its executive leadership team with the appointment of Sun Kim in Boston, MA as Chief Strategy & Investor Relations Officer.
CENTOGENE today announced the appointment of Dr. Carsten Ullrich, Ph.D. as Director of Artificial Intelligence to lead the company’s efforts […]
Combining genetic and biochemical testing to provide the most comprehensive screening for rare metabolic conditions
